Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.1400
-0.0300 (-17.65%)
May 20, 2026, 3:20 PM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $646.46 thousand as of May 21, 2026. Its market cap has decreased by -90.17% in one year.
Market Cap
646.46K
Enterprise Value
-945.24K
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 646.46K, a decrease of -97.61%. That is a compound annual growth rate of -66.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 646.46K | -22.28% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 922.59K |
| Aibotics | 892.39K |
| CERo Therapeutics Holdings | 844.36K |
| Halberd | 822.03K |
| Emmaus Life Sciences | 808.29K |
| Evofem Biosciences | 781.93K |
| Windtree Therapeutics | 773.79K |
| SQZ Biotechnologies Company | 707.79K |